Progress in Pediatric Cardiology
Volume 22, Issue 1 , Pages 85-93 , May 2006

Maternal autoimmune disease and its impact on the fetal heart: Management and prognosis

References 

  1. Rosenn B, Miodovnik M, Combs CA, Khoury J, Siddiqi TA. Glycemic thresholds for spontaneous abortion and congenital malformations in insulin-dependent diabetes mellitus. Obstet Gynecol. 1994;84:515–520
  2. Manderson JG, Mullan B, Patterson CC, Hadden DR, Traub AI, McCance DR. Cardiovascular and metabolic abnormalities in the offspring of diabetic pregnancy. Diabetologia. 2002;45:991–996
  3. Naeye RL. Infants of diabetic mothers: quantitative morphological study. Pediatrics. 1965;35:980–988
  4. Bjork O, Persson B. Villous structure in different parts of the cotyledon in placentas of insulin dependent diabetic women. Acta Obstet Gynecol Scand. 1984;63:37–43
  5. Nylund L, Lunell NO, Lewande R, Persson B, Sarby B. Utero placental blood flow in diabetic pregnancies. Am J Obstet Gynecol. 1982;144:298–302
  6. Salvesen DR, Brudenell MJ, Nicolaides KH. Fetal polycythemia and thrombocytopenia in pregnancies complicated by maternal diabetes mellitus. Am J Obstet Gynecol. 1992;166:1287–1292
  7. Jazayeri A, O'Brien WF, Tsibris JC, Spellacy WN. Are maternal diabetes and pre-eclampsia independent stimulators of erythropoietin production?. Am J Perinatol. 1998;15:577–580
  8. Wakasaki H, Koya D, Schoen F, et al. Targeted overexpression of protein kinase C β2 isoform in myocardium causes diabetic cardiomyopathy. Proc Natl Acad Sci U S A. 1997;94:9320–9325
  9. Finck BN, Lehman JJ, Leone TC, et al. The cardiac phenotype induced by PPAR alpha overexpression mimics that caused by diabetes mellitus. J Clin Invest. 2002;109:121–130
  10. Harris IS, Treskov I, Rowley MW, et al. G-protein signaling participates in the development of diabetic cardiomyopathy. Diabetes. 2004;53:3082–3090
  11. Meyer-Wittkopf M, Simpson JM, Sharland GK. Incidence of congenital heart defects in fetuses of diabetic mothers: a retrospective study of 326 cases. Ultrasound Obstet Gynecol. 1996;8:8–10
  12. Ferencz C, Rubin JD, McCarter RJ, Clark EB. Maternal diabetes and cardiovascular malformations: predominance of double outlet right ventricle and truncus arteriosus. Teratology. 1990;41:319–326
  13. Gutgesell HP, Mullins CE, Gillette PC, Speer M, Rudolph AJ, McNamara DG. Transient hypertrophic subaortic stenosis in infants of diabetic mothers. J Pediatr. 1976;89:120–125
  14. Tyrala EE. The infant of the diabetic mother. Obstet Gynecol Clin North Am. 1996;23:221–241
  15. Macklon NS, Hop WCJ, Wladimiroff JW. Fetal cardiac function and septal thickness in diabetic pregnancy: a controlled observational and reproducibility study. Br J Obstet Gynaecol. 1998;105:661–666
  16. Susa JB, McCormick KL, Widness JA, et al. Chronic hyperinsulinemia in the fetal rhesus monkey. Effects on fetal growth and composition. Diabetes. 1979;28:1058–1063
  17. Breitweser JA, Meyer RA, Sperling MA, et al. Cardiac septal hypertrophy in hyperinsulinemic infants. J Pediatr. 1980;96:535–538
  18. Campanaro J, Okun N, Stenstrom R, Garner PR. Macrosomia: the relative importance of diabetes as a predisposing factor. Am J Obstet Gynecol. 1991;164:136–137
  19. Jaeggi ET, Fouron JC, Proulx F. Fetal cardiac performance in uncomplicated and well-controlled maternal type 1 diabetes. Ultrasound Obstet Gynecol. 2001;17:311–315
  20. Sardesai MG, Gray AA, McGrath MMJ, Ford SE. Fatal hypertrophic cardiomyopathy in the fetus of a woman with diabetes. Obstet Gynecol. 2001;98:925–927
  21. Rizzo G, Arduini D, Romanini C. Cardiac function in fetuses of type I diabetic mothers. Am J Obstet Gynecol. 1991;164:837–843
  22. Rizzo G, Ardiuni D, Romanini C. Accelerated cardiac growth and abnormal cardiac flow in fetuses of type I diabetic mothers. Obstet Gynecol. 1992;80:369–376
  23. Weintrob N, Karp M, Hod M. Short- and long-range complications in offspring of diabetic mothers. J Diabetes Complications. 1996;10:294–301
  24. Mondestin MAJ, Ananth CV, Smulian JC, Vintzileos AM. Birth weight and fetal death in the United States: the effect of maternal diabetes during pregnancy. Am J Obstet Gynecol. 2002;187:922–926
  25. Zimmerman D. Fetal and neonatal hyperthyroidism. Thyroid. 1999;9:727–733
  26. McKenzie JM, Zakarija M. Fetal and neonatal hyperthyroidism and hypothyroidism due to maternal TSH receptor antibodies. Thyroid. 1992;2:155–159
  27. Matsuura N, Konishi J, Fujieda K, et al. TSH-receptor antibodies in mothers with Graves' disease and outcome in their offspring. Lancet. 1988;1:14–17
  28. Nachum Z, Rakover Y, Weiner E, Shalev E. Graves' disease in pregnancy: prospective evaluation of a selective invasive treatment protocol. Am J Obstet Gynecol. 2003;189:159–165
  29. Wallace C, Couch R, Ginsberg J. Fetal thyrotoxicosis: a case report and recommendations for prediction, diagnosis, and treatment. Thyroid. 1995;5:125–128
  30. Daneman D, Howard NJ. Neonatal thyrotoxicosis: intellectual impairment and craniosynostosis in later years. J Pediatr. 1980;257–259
  31. Chameides L, Trux RC, Vetter V, et al. Association of maternal lupus erythematosus with congenital complete heart block. N Engl J Med. 1977;297:1204–1207
  32. McCue CM, Mantakas ME, Tingelstad JB, et al. Congenital heart block in newborns of mothers with connective tissue disease. Circulation. 1977;56:82–90
  33. Buyon JP, Hiebert R, Copel J, et al. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from the national lupus registry. J Am Coll Cardiol. 1998;31:1658–1666
  34. Gladman G, Silverman ED, Yuk L, et al. Fetal echocardiographic screening of pregnancies of mothers with anti-Ro and/or anti-La antibodies. Am J Perinatol. 2002;19:73–80
  35. Brucato A, Frassi M, Franceschini F, et al. Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmuno-electrophoresis: a prospective study of 100 women. Arthritis Rheum. 2001;44:1832–1835
  36. Taylor PV, Scott JS, Gerlis LM, et al. Maternal antibodies against fetal cardiac antigens in congenital complete heart block. N Engl J Med. 1986;315:667–672
  37. Moak JP, Barron KS, Hougen TJ, et al. Congenital heart block: development of late-onset cardiomyopathy, a previously underappreciated sequela. J Am Coll Cardiol. 2001;37:238–242
  38. Nield LE, Silverman ED, Taylor GP, et al. Maternal anti-Ro and anti-La antibody associated endocardial fibroelastosis. Circulation. 2002;105:843–848
  39. Nield LE, Silverman ED, Smallhorn JF, et al. Endocardial fibroelastosis associated with maternal anti-Ro and anti-La antibodies in the absence of atrioventricular block. J Am Coll Cardiol. 2002;40:796–802
  40. Jaeggi ET, Fouron JC, Silverman ED, Ryan G, Smallhorn J, Hornberger LK. Transplacental treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease. Circulation. 2004;110:1542–1548
  41. Groves AMM, Allan LD, Rosenthal E. Outcome of isolated congenital complete heart block diagnosed in utero. Heart. 1996;75:190–194
  42. Jaeggi ET, Hamilton RM, Silverman ED, Hornberger LK. Outcome of children with fetal, neonatal or childhood diagnosis of isolated complete heart block. A single institutution's experience of 30 years. J Am Coll Cardiol. 2002;39:130–137
  43. Schmidt KG, Ulmer HE, Silverman NH, et al. Perinatal outcome of fetal complete atrioventricular block: a multicenter experience. J Am Coll Cardiol. 1991;17:1360–1366
  44. Waltuck J, Buyon JP. Autoantibody-associated congenital heart block: outcome in mothers and children. Ann Intern Med. 1994;120:544–551
  45. Saleeb S, Copel J, Friedman D, et al. Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody associated congenital heart block. Arthritis Rheum. 1999;42:2335–2345
  46. Buyon JP, Swersky SH, Fox HE, et al. Intrauterine therapy for presumptive fetal myocarditis with acquired heart block due to systemic lupus erythemathosus. Experience in a mother with a predominance of SS-B (La) antibodies. Arthritis Rheum. 1987;30:44–49
  47. Kaaja R, Julkunen H, Ammala P, et al. Congenital heart block: successful prophylactic treatment with intravenous gamma globulin and corticosteroid therapy. Am J Obstet Gynecol. 1991;165:1333–1334
  48. Brackley KJ, Ismael KMK, Wright JGC, et al. The resolution of fetal hydrops using combined maternal digoxin and dexamethasone therapy in a case of isolated complete heart block at 30 weeks gestation. Fetal Diagn Ther. 2000;15:355–358
  49. Carreira PE, Gutierrez-Larraya F, Gomez-Reino JJ. Successful intrauterine therapy with dexamethasone for fetal myocarditis and heart block in a woman with systemic lupus erythematosus. J Rheumatol. 1993;20:1204–1207
  50. Carpenter RJ, Strasburger JF, Garson A, et al. Fetal ventricular pacing for hydrops secondary to complete atrioventricular block. J Am Coll Cardiol. 1986;8:1434–1436
  51. Walkinshaw SA, Welch CR, McCormack J, et al. In utero pacing for fetal congenital heart block. Fetal Diagn Ther. 1994;9:183–185
  52. Weindling SN, Saul JP, Triedman JK, et al. Staged pacing therapy for congenital complete heart block in premature infants. Am J Cardiol. 1994;74:412–413
  53. Deloof E, Devlieger H, van Hoestenberghe R, et al. Management with a staged approach of the premature hydropic fetus due to complete congenital heart block. Eur J Pediatr. 1997;156:521–523
  54. Räsänen J. The effects of ritodrine infusion on fetal myocardial function and fetal hemodynamics. Acta Obstet Gynecol Scand. 1990;69:487–492
  55. Martin TC, Arias F, Olander DS, et al. Successful management of congenital atrioventricular block associated with hydrops fetalis. J Pediatr. 1988;112:984–986
  56. Harris JP, Alexson CG, Manning JA, Thompson HO. Medical therapy for the hydropic fetus with congenital complete atrioventricular block. Am J Perinatol. 1993;10:217–219
  57. Copel JA, Buyon JP, Kleinman CS. Successful in utero therapy of fetal heart block. Am J Obstet Gynecol. 1995;173:1384–1390
  58. Chan AYF, Silverman RK, Smith FC, et al. In utero treatment of fetal complete heart block with terbutaline. A case report. J Reprod Med. 1999;44:375–377
  59. Koike T, Minakami H, Shiraishi H, et al. Fetal ventricular rate in case of congenital heart block is increased by ritodrine. A case report. J Perinat Med. 1997;25:216–218
  60. Eronen M, Heikkila P, Teramo K. Congenital complete heart block in the fetus: hemodynamic features, antenatal treatment, and outcome in six cases. Pediatr Cardiol. 2001;22:385–392
  61. Barclay CS, French MAH, Ross LD, Sokol RJ. Successful pregnancy following steroid therapy and plasma exchange in a woman with anti-Ro (SS-A) antibodies. Case report. Br J Obstet Gynecol. 1987;94:369–371
  62. Van der Leu JN, Visser GHA, Bink-Boelkens MTE, et al. Successful outcome of pregnancy after treatment of maternal anti-Ro (SS-A) antibodies with immunosuppressive therapy and plasmapheresis. Prenat Diagn. 1994;14:1003–1007
  63. Rosenthal D, Druzin M, Chin C, Dubin A. A new therapeutic approach to the fetus with congenital complete heart block: preemptive, targeted therapy with dexamethasone. Obstet Gynecol. 1998;92:689–691
  64. Machado MV, Tynan MJ, Curry PV, Allan LD. Fetal complete heart block. Br Heart J. 1988;60:512–515
  65. Rosenthal D, Friedman DM, Buyon J, Dubin A. Validation of the Doppler PR interval in the fetus. J Am Soc Echocardiogr. 2002;15:1029–1030
  66. Sivarajah J, Huggon IC, Rosenthal E. Successful management of fetal hydrops due to congenitally complete atrioventricular block. Cardiol Young. 2003;13:380–383
  67. Minassian VA, Jazayeri A. Favorable outcome in a pregnancy with complete fetal heart block and severe bradycardia. Obstet Gynecol. 2002;100:1087–1089
  68. Robinson BV, Ettedgui JA, Sherman FS. Use of terbutaline in the treatment of complete heart block in the fetus. Cardiol Young. 2001;11:683–686
  69. Fouron JC, Proulx F, Miro J, et al. Doppler and M-mode ultrasonography to time fetal atrial and ventricular contractions. Obstet Gynecol. 2000;96:732–736
  70. Jaeggi ET, Silverman ED, Yoo SJ, Kingdom J. Is immune-mediated complete fetal atrio-ventricular block reversible by transplacental dexamethasone therapy?. Ultrasound Obstet Gynecol. 2004;23:602–605
  71. Sherman SJ, Featherstone LS. Congenital complete heart block and successful vaginal delivery. J Perinatol. 1997;17:489–491
  72. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmic devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation). J Am Coll Cardiol. 1998;31:1175–1209

PII: S1058-9813(06)00010-5

doi: 10.1016/j.ppedcard.2006.01.009

Progress in Pediatric Cardiology
Volume 22, Issue 1 , Pages 85-93 , May 2006

Article Tools

* Image Usage & Resolution